Yenidoğan sonrası üriner sistem infeksiyonları ve iki yıllık izlem sonuçları

Amaç: Kliniğimizde ilk semptomatik Üriner sistem infeksiyonu saptanan 160 çocuğun klinik, laboratuar özelliklerinin, 2 yıllık izlem ve komplikasyonlarının değerlendirilmesi amaçlandı. Yöntem: Klinik olarak Üriner sistem infeksiyonunu destekler en az 2 klinik/laboratuar bulgusu (atef, karın veya yan ağrısı, kusma, idrar yaparken ağrı, sık idrar, tam idrar tetkikinde piyüri) ve idrar kültüründe anlamlı üreme olan vakalar çalışmaya alındı. Bulgular: Vakaların 114'ü (% 71) kız, 46'sı (% 29) erkek ve ortalama yaşları 54$pm$44 ay 51-80), yaş gruplarına göre dağılımı 2 ay-23 ay % 33, 2 yaş-5 yaş % 21, >5 yaş % 46 idi. Ateş yüksekliği ve idrar yakınmaları en sık görülen klinik bulgulardı. Büyüme geriliği % 3 vakada saptandı. Vakaların % 31 'inde lökositoz (> 15,000 mm3) vardı, % 55 vakada C RP (>1 mg/dL) pozitif bulundu. Yüzde 44 vakada 30 mm/saat üzerinde olan sedimentasyon hızı ortalama 22±14 mm/saat (3-70) idi. Üre ve kreatin klirensi bir vaka dışında normal sınırlarda idi. Üreyen bakteriler sırasıyla; E.coli (% 62.7), Enterobacter spp (% 16.5), Proteus spp (% 8.9), Klebsiella spp (% 8.9), diğer (% 3) olarak bulundu. Renal ultrasonografi % 30, DMSA % 63 vakada patolojik olup, voiding sistoüretrografide % 23 vakada vezikoüreteral reflü saptandı. Profilaktik antibiyotik endikas-yonu vakaların % 56'sına konuldu, profilaksi öncesi üreme sayısı 1.5$pm$0.9, profilaksi öncesi izlem süresi 2±1 ay idi. Profilakside en sık kotrimoksazol (% 70) ve nitrofurantoin (% 17) verildi. Ortalama l4±7'ay (1-26)profilaksi verildi ve bu sürede ortalama 1$pm$1 üreme saptandı Sonuç: Vakaların izlem sırasında kontrol altına alınamayan Üriner sistem İnfeksiyonları olmadı ve hiçbir vakada ciddi komplikasyon gelişmedi.

Urinary tract infections in postneonatal period and results of two year follow-up

Aim: Clinical and laboratory features and two-years fol-low-up were evaluated in 160 children with the first symptomatic urinary tract infection in our clinic. Method: The patients with a least two clinical/laboratory findings (fever, abdominal/side pain, vomiting, dysuria, pollacuria, and pyuria) plus positive significant urinary culture results were included in the study. Results: Mean age was 54$pm$44 (1-180) months (mean$pm$SD, range), 71 % female (114) and 29 % (46) male, distrubition according to age group; 2 months- 23 months 33 %, 2 years-5 years 21 %, >5 years 46 %. The most prominent clinical findings were fever and urinary symptoms. Growth failure was detected in 3 % of the patients. Thirty-one per-cent of patients had leucocytosis (>15.000), 55 % had elevated CRP (> 1 mg/dL), and 44 % had elevated ESR levels. Urea and creatinin levels were in the normal ranges except for one patient. Urine culture results were revealed as E. coli (62.7 %), Enterobacter spp (16.4 %), Proteus 'spp (8.9 %), Klebsiella spp (8.9 %), and others (3 %). Renal ultrasound was found pathologic in 30 % of the patients (19 % dilatation, 19 % increased echogenity), VUR was detected in 23 % of the patients by VCUG. Sixty-three percent of the patients had pathologic scintigraphic results (23 % scar, 40 % perfusion defects). Prophylactic antibiotic was given 56 % of the patients. The mean number of positive cultures was 1.5±0.5 before prophlaxis (the mean follow-up time 2$pm$1 months), and 1$pm$1 after prophyaxis (the mean follow-up time 14±7 months). There were no un-controlled urinary tract infection in the follow-up, and no case had any complications due to urinary tract infection. Conclusion: There were no uncontrolled urinary tract infection in the follow-up, and no case had any complications due to urinary tract infection.

___

  • 1. Hellström A, Hanson E, Hansson S, Hjalmaş K, Jodal U.Association between urinary symptoms at 7 years old and previous urinary tract infection. Arch Dis Child 1991; 66:232-4.
  • 2. Subcommittee on urinary tract infection. Committee on quality improvement. Clinical practice guideline: The diagnosis, treatment and evaluation of the initial urinary tract infection in febrile infants and young children. In: CEnical practice quideline of American Academy of Pediatrics, 3rd ed, 2000: 337-61.
  • 3. Berg U, Johansson SBi Age as a main determinant of renal functional damage in urinarytract infection. Arch Dis Child 1983; 58:963-9. 4. Winberg J, BoUgren I, Kallanius G, Möllby R, Svensson S. Clinical pyelonephritis and focal renal scarring. A selected review of pathogenesis, prevention and prognosis. Pediatr Clin North Am 1982; 29: 801-14.
  • 5. Dick PT, Feldman W. Routine diagnostic imaging for children urinary tract infections: A systematic overview. J Pediatr 1996; 128:15-22.
  • 6. Rosenberg AR, Rossleigh MA, Brydon MP, Bass SJ, Leighton DM, Farnsworth RH. Evaluation of acute urinary tract infection in children DMSA scintigraphy: a prospective study. J Urol 1992; 148: 1746-9.
  • 7. Tappin DM, Murphy AV, Mocan H, et al. A prospective study of children with first acute symptomatic £. coli urinary tract infection: early DMSA scan appeareances. Acta Paediatr Scand 1989; 78:923-9.
  • 8. Pylkkanen J, Vilska J, Koskimies O. The value of level diagnosis of childhood urinary tract infection in predicting renal injury. Acta Paediatr Scand 1981; 70:879-83.
  • 9. Hellstrom M, Jacobsson B, Marild S, Jodal U. Voiding ciys-tourethorography as a predictor of reflux nephropathy in children with urinary tract infecton. AJR 1989; 152:801-4.
  • 10. Merrick MV, Nothgi A, Chalmers N, Wilkinson AG, Uttley WS. Long-term follow up to determine the prognostic value of imaging after urinary tract infection. Part 2: scarring. Arch Dis Child 1995; 72: 393-6.
  • 11. Smellie JM, Normand ICS, Katz G. Children with urinary infection: a comparison between those with and those without vesicoureteric reflux. Kidney Int 1981; 20:717-22.
  • 12. Hoberman A, Charron M, Hickey RW, Baskin M, Kearney DH, Wald ER. Imaging studies after a first febrile urinary tract infection in young children. N Engl J Med 2003; 348: 195-202.
  • 13. Winberg J, Andersen HJ, Bergström T, Jacobsson B, Larson H, Lincoln K. Epidemiology of symptomatic urinary tract infection in childhood. Acta Paediatr Scand 1974; Suppl 252: 1-20.
  • 14. Jacobson SH, Eklöf AC, Eriksson CG, Lins LE, Tidgren B, Winberg J. Development of hypertension and uraemia after pyelonephritis in childhood: 27 year follow up. BMJ 1989; 299: 703-6.
  • 15. Bollgren I. Antibacterial prophylaxis in children with urinary tract infection. Acta Paediatr Suppl 1999; 431: 48-52.
  • 16. Nayir A. Circumcision for the prevention of significant bacteriuria in boys. Pediatr Nephrol 2001; 16: 1129-34.
  • 17. Benador D, Neuhaus TJ, Papazyan JJP, et al. Randomised controlled trial of three day versus 10 day intravenous antibiotics in acute pyelonephritis: effect on renal scarring. Arch Dis Child 2001; 84: 241-6.
  • 18. Desphande PV, Jones KV. An audit of RCP guidelines on DMSA scanning after urinary tract infection. Arch Dis Child 2001; 84: 324-7.
  • 19. Stokland E, Hellström M, Hansson S, et al. Reliability of ultrasonography in identificaton of reflux nephropathy in children. BMJ 1994; 309: 235-9.
  • 20. Smellie JM, Rigden SPA, Prescod NP. Urinary tract infection: a comparison of four methods of investigation. Arch Dis Child 1995; 72: 247-50.
  • 21. Mahant S, Friedman J, MacArthur C. Renal ultrasound findings and vesicoureteral reflux in children hospitalised with urinary tract infection. Arch Dis Child 2002; 86: 419-21.
  • 22. Christian Mt, McColl JH, Mackenzie JR, Beattie TJ. Risk assessment of renal cortical scarring with urinary tract infection by clinical features and ultrasonography. Arch Dis Child 2002; 82: 376-80.
  • 23. Rodopman R, Nayir A, Alpay H, et al. Evaluation of pathology by Technetium labeled dimercaptosuccinic acid scan, intravenous urography, ultrasonography and voiding cystourethrogra-phy: a retrospective comparative study. Med Bull, Istanbul 1995; 28: 50-3.
  • 24. Jakobsson B, Svensson L. Transient pylenephritis changes on DMSA scan for at least five months after infection. Acta Paediatr 1997; 86: 803-7.
  • 25. Stokland E, Helstrom M, Jacobsson BJ, Jodal U, Sixt R. Renal damage after first urinary tract infection: role of dimercap tosuccinic acid scintigraphy. J Pediatr 1996; 129: 815-20.
  • 26. Shah KJ, Robins DG, White RH. Renal scarring and vesi-coureteric reflux. Arch Dis Child 1978; 53: 210-7.
  • 27. Berg UB. Long-term follow-up of renal morphology and function in children with recurrent pyelonephritis. J Urol 1992; 148: 1715-20.
  • 28. Filly R, Friedland GW, Govan DE, Fair WR. Development of progression of clubbing and scarring in children with recurrent urinary tract infections. Radiology 1974; 113: 145-53.
  • 29. Pomeranz A, El-Khayam A, Kortzets Z, et al. A bioassay evaluation of the urinary antibacterial efficacy of low dose prophylactic antibiotics in children with vesicoureteral reflux. J Urology 2000; 164: 1070-3.
  • 30. Tamminen-Mobius T, Brunier E, Ebel KD, et al. Cessation of vesicoureteral reflux for 5 years in infants and children allocated to medical treatment. The International Reflux Study in children. J Urol 1992; 148: 1662.
  • 31. Birmingham Reflux Study Group: Prospective trial of operative versus non-operative treatment of severe vesicoureteric reflux in children: five years' observation. BMJ 1987; 295: 237-41.
  • 32. Weiss R, Duckett J, Spitzer A. Results of a randomized clinical trial of medical versus surgical management of infants and children with grades HI and IV primary vesicoureteral reflux. J Urol 1992; 148: 1653-6.
  • 33. Olbing H, Claesson I, Ebel KD, et al. Renal scars and parenchymal thinning in children with vesicoureteral reflux: A 5 year report of the International Reflux Study of Children. J Urol 1992; 148: 1653-6.
Çocuk Dergisi-Cover
  • ISSN: 1302-9940
  • Yayın Aralığı: Yılda 4 Sayı
  • Başlangıç: 2000
  • Yayıncı: İstanbul Üniversitesi